Luo, J., Makhnin, A., Tobi, Y., Ahn, L., Hayes, S. A., Iqbal, A., . . . Yu, H. A. (2021). Erlotinib and Trametinib in Patients With EGFR-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor. JCO Precis Oncol.
Citação norma ChicagoLuo, Jia, et al. "Erlotinib and Trametinib in Patients With EGFR-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor." JCO Precis Oncol 2021.
Citação norma MLALuo, Jia, et al. "Erlotinib and Trametinib in Patients With EGFR-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor." JCO Precis Oncol 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.